Adipose-derived regenerative cells for treating liver injury
    32.
    发明授权
    Adipose-derived regenerative cells for treating liver injury 有权
    用于治疗肝损伤的脂肪来源的再生细胞

    公开(公告)号:US09198937B2

    公开(公告)日:2015-12-01

    申请号:US13725814

    申请日:2012-12-21

    摘要: Cells present in processed lipoaspirate tissue are used to treat patients. Methods of treating patients include processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient. The methods may be practiced in a closed system so that the stem cells are not exposed to an external environment prior to being administered to a patient. Compositions that are administered to a patient include a mixture of adipose tissue and stem cells so that the composition has a higher concentration of stem cells than when the adipose tissue was removed from the patient.

    摘要翻译: 存在于加工的lipoaspirate组织中的细胞用于治疗患者。 治疗患者的方法包括加工脂肪组织以将从脂肪组织获得的浓缩量的干细胞输送给患者。 所述方法可以在封闭系统中实施,使得干细胞在施用于患者之前不暴露于外部环境。 施用于患者的组合物包括脂肪组织和干细胞的混合物,使得组合物具有比从患者中除去脂肪组织时更高浓度的干细胞。